- $6.15m
- $5.00m
- $2.55m
Annual balance sheet for ENvue Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 7.74 | 2.71 | 3.28 | 0.752 | 4.22 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.264 | 0.109 | 0.425 | 0.268 | 0.543 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8.34 | 5.61 | 6.49 | 3.33 | 7.27 |
| Net Property, Plant And Equipment | 0.054 | 0.088 | 0.012 | 0.125 | 0.246 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 8.62 | 5.88 | 6.67 | 3.63 | 41.1 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.9 | 2.32 | 2.45 | 2.72 | 6.66 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.31 | 2.65 | 2.69 | 3 | 7.63 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 6.31 | 3.23 | 3.99 | 0.627 | 33.5 |
| Total Liabilities & Shareholders' Equity | 8.62 | 5.88 | 6.67 | 3.63 | 41.1 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |